Saturday, May 18, 2013 Last update: 5:34 AM
Company Tech News as it Breaks
Trade Events
Stentys
News articles for Stentys:
Wednesday, March 27, 2013
- STENTYS Reports 2012 Financial ResultsSTENTYS (FR0010949404 – STNT), a medical technology company commercializing, in Europe, the world's first and only Self-Apposing® stent to treat acute myocardial infarction (AMI), today announced its ... read more
Saturday, March 9, 2013
- STENTYS Self-Apposing® Stent Demonstrates Lowest Mortality Rate Among Large Heart Attack TrialsSTENTYS (FR0010949404 – STNT), a medical technology company commercializing in Europe the world's first and only Self-Apposing® Stent to treat acute myocardial ... read more
Tuesday, February 26, 2013
- STENTYS to Present Final Results From 1,000 Heart Attack Patient Study at ACC.13STENTYS (FR0010949404 – STNT), a medical technology company commercializing in Europe the world's first and only Self-Apposing® Stent to treat acute myocardial ... read more
Thursday, January 3, 2013
- STENTYS Clinical Study Demonstrating Superiority of Self-Apposing® Stents Over Conventional Stents Published in American College of Cardiology JournalSTENTYS (FR0010949404 – STNT), a medical technology company commercializing in Europe the world's first and only Self-Apposing® stent to treat acute myocardial ... read more